Cargando…
Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine
BACKGROUND: The objective of this study was to summarize clinical features and PRRT2 mutations of paediatric paroxysmal kinesigenic dyskinesia (PKD) patients and observe the tolerability and effects of morning draughts of oxcarbazepine. METHODS: Twenty patients diagnosed with PKD at Children’s Hospi...
Autores principales: | Pan, Gang, Zhang, Linmei, Zhou, Shuizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854699/ https://www.ncbi.nlm.nih.gov/pubmed/31722684 http://dx.doi.org/10.1186/s12887-019-1798-7 |
Ejemplares similares
-
PRRT2 Gene Mutations in Indian Paroxysmal Kinesigenic Dyskinesia Patients
por: Prabhakara, S., et al.
Publicado: (2021) -
Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias
por: Wang, Jun-Ling, et al.
Publicado: (2011) -
Brain structural connectome in relation to PRRT2 mutations in paroxysmal kinesigenic dyskinesia
por: Li, Lei, et al.
Publicado: (2020) -
Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia
por: Hedera, Peter, et al.
Publicado: (2012) -
Successful control with carbamazepine of family with paroxysmal kinesigenic dyskinesia of PRRT2 mutation
por: Chou, I-Ching, et al.
Publicado: (2014)